Allison DB, Newcomer JW, Dunn AL, et al. Obesity Among Those with Mental Disorders. A National Institute of Mental Health Meeting Report. Am J Prev Med 2009; 36(4): 341-350.
BALANCE investigators and collaborators, Geddes JR, Goodwin GM, Rendell J, Azorin JM, Cipriani A, Ostacher MJ, Morriss R, Alder N, Juszczak E. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomized open-label trial. Lancet. 2010 Jan 30: 375(9712): 385-95.
Baldessarini RJ, Cohen BN, Teicher MH: Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry, 1988; 45: 79-91.
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders 2013 Feb; 15(1): 1-44.
Cipriani A, Barbui C, Salanti G, et al. Comparative efficacy and acceptability of Antimanic drugs in acute mania: a multiple-treatments meta-analysis. Lancet, 2011, Oct 8; 378(9799): 1306-15.
Connolly RK, Thase ME. If at first you don't succeed. A review of the evidence for antidepressant augmentation, combination and switching strategies. Drugs 2011; 71 (1): 43-64.
Geddes JR, Calabrese JR, and Goodwin GM. Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomized trials. Br J Psychiatry 2009; 194: 4-9.
Kane JM. Schizophrenia. NEngl J Med 1996; 334(1): 34-41.
Ketter TA, Citrome L, and Wang PW et al. Treatments for bipolar disorder: can number needed to treat harm help inform clinical decisions? Acta Psychiatric Scandinavica 2011: 123: 175-189.
Ketter TA. Handbook of Diagnosis and Treatment of Bipolar Disorder. Washington, DC: American Psychiatric Publishing Inc., 2010. Lam DH, Watkins ER, Hayward P et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003; 60: 145-152.
Lam RW, Kennedy SH, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT). Canadian Network for Mood and Anxiety Treatments clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 2009; 117 Suppl. 1: S26-43.
Leucht S, Corves C, Arbter D, et al. Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis. Lancet, 2009 Jan 3; 373(9657): 31-41.
Miklowitz, DJ, Otto MW, Frank et al. Intensive psychosocial intervention enhances functioning in patients with bipolar depression: Results from a 9-month randomized controlled trial. Am J Psychiatry. 2007 Sep; 164(9): 1340-7.
Mirklowitz DJ, George EL, Richards JA, et al. A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 2003;60:904-912.
Sachs GS, Nierenberg AA, Calabrese JR et al. Effectiveness of antidepressant for bipolar depression. N Engl J Med 2007; 356: 1711-1722.
Schizophrenia, "Just the Facts" 5. Treatment and prevention past, present, and future. Tandon, R, Nasrallah HA, Keshavan MS. Schizophrenia Research.
Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disorders 2013 Feb; 15(1): 1-44.
Suppes T, Liu S, Brecher M, Paulsson B, et al: Maintenance treatment for patients with bipolar I disorder: Results from North American Study of quetiapine in combination with lithium or divalproex. Am J Psychiatry, 2009 Apr; 166(4): 476-88.
Suppes T, Vieta E, Liu S et al. Maintenance Treatment for patients with bipolar I disorder: results from a North American study of quetiapine in combination with Lithium or divalproex (trial 127). Am J Psychiatry 2009; 166: 476-488.
Tandon R, Belmaker RH, Gattaz WF, et al. World Psychiatric Association Pharmacopsychiatry Section Statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia. Schizophrenia Research, 2008; 100(1-3): 20-38.
Thase ME, Jonas A, Khan A, et al. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies. J ClinPsychopharmacol 2008; 28:13-20
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements. Buchanan RW, Kreyenbuhl J, Kelly DL, et al. Schizophrenia Bulletin 2010; 36(1): 71-93.